未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis lonafarnib和利托那韦联合或不联合干扰素 α 治疗慢性丁型肝炎的2期剂量研究 Yurdaydin, Cihan; Keskin, Onur; Yurdcu, Esra; Caliskan, Aysun; Onem, Soner; Karakaya, Fatih; Kalkan, Cagdas; Karatayli, Ersin; Karatayli, Senem; Choong, Ingrid; Apelian, David; Koh, Christopher; Heller, Theo; Idilman, Ramazan; Bozdayi, A. Mithat; Glenn, Jeffrey S. 分享 收藏
Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery Ozbas, Burak; Keskin, Onur; Hecker, Hartmut; Karahan, Irfan; Ozbas, Cansu; Kalkan, Cagdas; Kartal, Aysun; Onder, Fatih Oguz; Oncu, Burcu Kahveci; Gencdal, Genco; Akyildiz, Murat; Gunsar, Fulya; Idilman, Ramazan; Weissenborn, Karin; Ozutemiz, Omer; Yurdaydin, Cihan 分享 收藏
分享 收藏
Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads Yurdaydin, C.; Kalkan, C.; Karakaya, F.; Caliskan, A.; Karatayli, S.; Keskin, O.; Idilman, R.; Bozdayi, M.; Koh, C.; Heller, T.; Glenn, J. 分享 收藏
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study 优化lonafarnib治疗慢性丁型肝炎的管理: LOWR HDV-1研究 Yurdaydin, Cihan; Keskin, Onur; Kalkan, Cagdas; Karakaya, Fatih; Caliskan, Aysun; Karatayli, Ersin; Karatayli, Senem; Bozdayi, A. Mithat; Koh, Christopher; Heller, Theo; Idilman, Ramazan; Glenn, Jeffrey S. 分享 收藏
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease 慢性丁型肝炎患者的干扰素治疗持续时间及其对疾病自然病程的影响 Yurdaydin, Cihan; Keskin, Onur; Kalkan, Cagdas; Karakaya, Fatih; Caliskan, Aysun; Kabacam, Gokhan; Onder, F. Oguz; Karatayli, Senem; Karatayli, Ersin; Deda, Xheni; Bozkaya, Hakan; Bozdayi, A. Mihat; Idilman, Ramazan 分享 收藏
分享 收藏
The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis Yurdaydin, C.; Idilman, R.; Kalkan, C.; Karakaya, M. F.; Caliskan, A.; Keskin, O.; Yurdcu, E.; Karatayli, S. C.; Bozdayi, M.; Koh, C.; Heller, T.; Glenn, J. 分享 收藏
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-end of treatment results from the LOWR HDV-2 study Yurdaydin, C.; Idilman, R.; Keskin, O.; Kalkan, C.; Karakaya, M. F.; Caliskan, A.; Yurdcu, E.; Karatayli, S. C.; Bozdayi, M.; Koh, C.; Heller, T.; Glenn, J. 分享 收藏
分享 收藏
分享 收藏